Rentokil Initial/£RTO

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About Rentokil Initial

Rentokil Initial plc, ticker RTO, is a United Kingdom-based company specializing in pest control, hygiene, and wellbeing services. The company operates globally with a presence in regions including North America, Europe, the UK, Asia, and the Pacific. Founded in 1925, Rentokil Initial has grown to become a leader in providing services that ensure environments are clean, safe, and healthy.

Ticker

£RTO

Sector

Business services

Primary listing

LSE

Employees

68,485

Rentokil Initial Metrics

BasicAdvanced
£11B
43.12
£0.10
0.33
£0.09
2.14%

What the Analysts think about Rentokil Initial

Analyst ratings (Buy, Hold, Sell) for Rentokil Initial stock.

Bulls say / Bears say

Rentokil agreed to sell its French workwear business to H.I.G. Capital for about €410 million (net proceeds of ~€370 million), a deal that will streamline operations and strengthen the balance sheet ahead of integration expenses (WSJ).
In H1 2025, free cash flow increased to $282 million—31.2% higher than in H1 2024—with adjusted free cash flow conversion at 93%, beating the 80% target, improving liquidity to support growth and reduce debt (Reuters).
Group organic revenue rose 1.6% in H1 2025, with International up 2.7% and North America strengthening to 1.1% (1.4% in Q2 versus 0.7% in Q1), indicating broad-based resilience and initial benefits from marketing and integration efforts (Reuters).
Adjusted operating profit fell 4.7% year-on-year in H1 2025, with group adjusted operating margin declining 120 basis points to 15.2%, showing margin pressure, particularly from weaker North American volumes and rising costs (Reuters).
Non-recurring and adjusting items reached $110 million in H1 2025, including a $79 million increase in reserves for termite damage claims, resulting in a 7.8% drop in adjusted profit before tax and highlighting uncertainty in pest control liabilities (Reuters).
Net debt as of 30 June 2025 increased to $4.22 billion, with net debt to adjusted EBITDA at 2.8x, limiting financial flexibility ahead of a $700 million term loan due in October 2025 and raising refinancing risk (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2025.

Rentokil Initial Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Rentokil Initial Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £RTO

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs